19189435

Source:http://linkedlifedata.com/resource/pubmed/id/19189435

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013126, umls-concept:C0019932, umls-concept:C0038302, umls-concept:C0332325, umls-concept:C0376358, umls-concept:C0920321, umls-concept:C1456348, umls-concept:C1705313, umls-concept:C1999216, umls-concept:C2607886
pubmed:issue	6
pubmed:dateCreated	2009-2-2
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19189435-18645193
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7512719
pubmed:status	PubMed-not-MEDLINE
pubmed:month	Dec
pubmed:issn	0302-2838
pubmed:author	pubmed-author:SchalkenJack AJA
pubmed:issnType	Print
pubmed:volume	54
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1438-9
pubmed:year	2008
pubmed:articleTitle	Words of wisdom. Re: phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration- resistant prostate cancer commonly remains hormone driven.
pubmed:affiliation	Department of Urology, Radboud University Nijmegen Medical Center, Postbus 9101, 6500 HB, Nijmegen, the Netherlands. J.Schalken@uro.umcn.nl
pubmed:publicationType	Journal Article, Comment